Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   
 

Abstract | Full HTML Article | PDF ecancer 13 993 / https://doi.org/10.3332/ecancer.2019.993

Research

IMRT and brachytherapy comparison in gynaecological cancer treatment: thinking over dosimetry and radiobiology

Background: The role of radiotherapy and brachytherapy in the management of locally advanced cervical and endometrial cancer is well established. However, in some cases, intracavitary brachytherapy (ICBRT) is not recommended or cannot be carried out. We aimed to investigate whether external-beam irradiation delivered by means of intensity-modulated radiation therapy (IMRT) might replace ICBRT in gynaecological cancer when the standard ICBRT boost delivering cannot be administered for technical or clinical reasons.

Materials and methods: Fifteen already delivered treatments for gynaecological cancer patients were analysed. The treatments were performed through 3-dimensional conformal radiotherapy (3D-CRT) to the whole-pelvis up to the dose of 45–50.4 Gy followed by a boost dose administered with ICBRT in high-dose-rate or pulsed-dose-rate modality. For each patient, IMRT plans were elaborated to mimic the ICBRT. We analysed the ICBRT boost versus IMRT boost in terms of dosimetric and radiobiological aspects.

Results: Mean conformity index value calculated on boost volume was 0.73 for ICBRT and 0.97 for IMRT. Mean conformation number was 0.24 for ICBRT boost and 0.78 for IMRT boost. Mean normal tissue complication probability (NTCP) values for 3D-CRT plus ICBRT and for IMRT (pelvis plus boost) were, respectively, 28% and 5% for rectum; 1.5% and 0.1% for urinary bladder and 8.9% and 6.1% for bowel.

Conclusions: Our findings suggest that IMRT may represent a viable alternative in delivering the boost in patients diagnosed with gynaecological cancer not amenable to ICBRT.

Keywords: cervical cancer, endometrial cancer, brachytherapy, IMRT, radiobiology, dosimetry

Loading Article Metrics ... Please wait

Related articles

Clinical Study: Computational analyses on genetic alterations in the NSD genes family and the implications for colorectal cancer development

Abstract | Full Article | PDF Published: 15 Jan 2020 / https://doi.org/10.3332/ecancer.2020.1001

Research: The clinical-care focused psychological interview (CLiC): a structured tool for the assessment of cancer patients’ needs

Abstract | Full Article | PDF Published: 13 Jan 2020 / https://doi.org/10.3332/ecancer.2020.1000

Clinical Study: Factors affecting weight and body composition in childhood cancer survivors—cross-sectional study

Abstract | Full Article | PDF Published: 13 Jan 2020 / https://doi.org/10.3332/ecancer.2020.999

Conference Report: Highlights from the 2019 International Aspirin Foundation Scientific Conference, Rome, 28 June 2019: benefits and risks of antithrombotic therapy for cardiovascular disease prevention

Abstract | Full Article | PDF Published: 13 Jan 2020 / https://doi.org/10.3332/ecancer.2020.998

Review: Cancer prevention programmes in Mexico: are we doing enough?

Abstract | Full Article | PDF | Español Published: 06 Jan 2020 / https://doi.org/10.3332/ecancer.2020.997



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation